| | | |   | | | | By Ed Silverman and Casey Ross Adobe Merative, which was formed using assets from IBM Watson Health, will no longer provide the media with information on drug pricing changes. Read More | | By Jason Mast Ric Francis/AP Amgen's candidate works similarly to Lilly and Novo drugs, but with a twist that could induce greater, longer-lasting weight loss. Read More | | By Damian Garde and Jonathan Wosen Adobe Some researchers concluded that investigational medicines might need to clear out substantial amounts of amyloid in order to show a benefit. Read More | | Sponsored Insight by STAT TRIALS PULSE Could warning signs in Summit Therapeutics' clinical trial activity have hinted at bad results months before they were announced? There are an average of over 6,800 clinical trials updates every day. Trying to analyze these changes and identify patterns is a staggering but essential undertaking for life sciences professionals seeking competitive intelligence. That's where STAT Trials Pulse steps in. We connect disparate sources of clinical trials data, detect important updates, and add context to deliver a curated stream of actionable alerts. Learn more at statnews.com/trials-pulse, or start your 30-day free trial.
| | By Brittany Trang Adobe The recall of millions of CPAP machines and other breathing devices made by Philips underscores critical shortcomings of device oversight. Read More | |
No comments